Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02803255 · ClinicalTrials.gov registry record · Phase 1

AAN Robotic Therapy in SCI

A Phase 1 study, sponsored by William Marsh Rice University.

Completed
Registry status
Phase 1
Development phase
14
Enrollment target

NCT02803255: Completed Phase 1 study, sponsored by William Marsh Rice University.

NCT02803255 is a Phase 1 study that has completed, run by William Marsh Rice University. The registered enrollment target is 14 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02803255, a Phase 1 study, has completed, sponsored by William Marsh Rice University.

COMPLETED
Registry status
Phase 1
Development phase
14 participants
Enrollment target

Study Summary

The purpose of this study is to demonstrate that a robot-aided rehabilitation protocol that follows the "assist-as needed" paradigm provide statistically significant improvements in arm and hand motor functions when compared to robot-aided protocols that passively move patients' arms along pre-defined trajectories, in patients with incomplete spinal cord injury (SCI).

Interventions

  • DEVICE MAHI Exo-II

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2014-05
Est. Completion 2015-09
Phase Phase 1
William Marsh Rice University

8 total trials

What the finished NCT02803255 record still lists

NCT02803255 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (77% lower).

The record links to 0 conditions, and to 1 intervention - of which MAHI Exo-II is the first listed.

NCT02803255 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02803255 about?

NCT02803255 is a clinical study titled "AAN Robotic Therapy in SCI". The purpose of this study is to demonstrate that a robot-aided rehabilitation protocol that follows the "assist-as needed" paradigm provide statistically significant improvements in arm and hand motor functions when compared to robot-aided protocols that passively move patients' arms along pre-defin...

What is the current status of trial NCT02803255?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2014-05. Estimated completion is 2015-09.

What interventions are being tested in trial NCT02803255?

The interventions under investigation include: MAHI Exo-II (DEVICE).

Who is sponsoring clinical trial NCT02803255?

This trial is sponsored by William Marsh Rice University, which has 8 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02803255's enrollment target sits among peer trials

14 1844th of 2000 higher than 154 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02523092 · 14 participants · Phase 4

    Use of CXCL9 as a Biomarker of Acthar Efficacy

  • NCT04263285 · 14 participants · NA

    Treatment of Depression Post-SCI

  • NCT04743271 · 14 participants · NA

    Food and Circadian Timing

  • NCT05065671 · 14 participants · Phase 1

    Microbiome Derived Metabolism and Pharmacokinetics

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02803255, the US trial registry maintained by the National Library of Medicine. NCT02803255 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.